J. G. Ribeiro

发表

Characterization of main cytokine sources from the innate and adaptive immune responses following primary 17DD yellow fever vaccination in adults.

A. Teixeira-Carvalho, E. Kroon, D. Silveira-Lemos, 2011, Vaccine.

Activation/modulation of adaptive immunity emerges simultaneously after 17DD yellow fever first‐time vaccination: is this the key to prevent severe adverse reactions following immunization?

A. Teixeira-Carvalho, R. Corrêa-Oliveira, E. Kroon, 2007, Clinical and experimental immunology.

Anemia and nutritional aspects in adolescent athletes: a cross-sectional study in a reference sport organization

J. Lamounier, J. G. Ribeiro, F. D. Capanema, 2021, Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo.

CCL3, CCL5, IL-15, IL-1Ra and VEGF compose a reliable algorithm to discriminate classes of adverse events following 17DD-YF primary vaccination according to cause-specific definitions.

A. Teixeira-Carvalho, L. R. Amaral, M. de Souza Gomes, 2021, Vaccine.

[Active and passive immunization in the extremely preterm infant].

E. C. Tavares, J. G. Ribeiro, L. A. Oliveira, 2005, Jornal de pediatria.

Short-Lived Immunity After 17DD Yellow Fever Single Dose Indicates That Booster Vaccination May Be Required to Guarantee Protective Immunity in Children

A. Teixeira-Carvalho, L. Camacho, P. Tauil, 2019, Front. Immunol..

17DD Yellow Fever Revaccination and Heightened Long-Term Immunity in Populations of Disease-Endemic Areas, Brazil

A. Teixeira-Carvalho, P. Tauil, O. Martins-Filho, 2019, Emerging infectious diseases.

Innate immunity phenotypic features point toward simultaneous raise of activation and modulation events following 17DD live attenuated yellow fever first-time vaccination.

A. Teixeira-Carvalho, E. Kroon, O. Martins-Filho, 2008, Vaccine.

Impact of six years of routine varicella vaccination on the disease-related hospitalizations at Minas Gerais, Brazil.

J. G. Ribeiro, Victor Adalberto Machado Nascimento, C. Greco, 2021, Vaccine.

17DD and 17D-213/77 Yellow Fever Substrains Trigger a Balanced Cytokine Profile in Primary Vaccinated Children

Luiz Antonio Bastos Camacho, Ana Carolina Campi-Azevedo, Olindo Assis Martins-Filho, 2012, PloS one.

Risk of fatal adverse events associated with 17DD yellow fever vaccine

C. Struchiner, C. Codeço, P. Luz, 2004, Epidemiology and Infection.

Yellow fever in children and adolescents previously immunized in Minas Gerais State, Brazil.

J. G. Ribeiro, R. Romanelli, L. M. Diniz, 2020, Vaccine.